Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression

Acta Oto-Laryngologica

Volumn 134, Issue 2, 2014, Pages 185-192

  Zhang, Chi ^a   Yang, Xi ^a   Zhang, Qu ^b   Yang, Baixia ^c   Xu, Liping ^a   Qin, Qin ^a   Zhu, Hongcheng ^a   Liu, Jia ^a   Cai, Jing ^c   Tao, Guangzhou ^d   Ma, Jianxin ^e   Ge, Xiaolin ^a   Zhang, Sheng ^a   Cheng, Hongyan ^a   Sun, Xinchen ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

^c NANTONG TUMOR HOSPITAL   (China)

^d THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e Second People's Hospital of Lianyungang   (China)

Author keywords

HIF 1 ; Radiotherapy; VEGF

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BERBERINE; BETA ACTIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CELL HYPOXIA; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; RADIOSENSITIZATION; TUMOR XENOGRAFT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BERBERINE; CARCINOMA; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; RADIATION TOLERANCE; RADIATION-SENSITIZING AGENTS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84892726613     PISSN: 00016489     EISSN: 16512251     Source Type: Journal    
DOI: 10.3109/00016489.2013.850176     Document Type: Article

References (18)

1. Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012;33:207-14.
2. Rozman A, Silar M, Kosnik M. Angiogenin and vascular endothelial growth factor expression in lungs of lung cancer patients. Radiol Oncol 2012;46:354-9.
3. Liu Q, Jiang H, Liu Z, Wang Y, Zhao M, Hao C, et al. Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS ONE 2011;6:e23427.
4. Wang J, Liu Q, Yang Q. Radiosensitization effects of berberine on human breast cancer cells. Int JMol Med 2012;30: 1166-72.
5. Lee AW, Ng WT, Chan YH, Sze H, Chan C, Lam TH. The battle against nasopharyngeal cancer. Radiother Oncol 2012; 104:272-8.
6. Huang PY, Sun ZY, Xie CM, Chen QY, Wen YF, Li J, et al. Prognostic significance of the various classifications for parapharyngeal space involvement in nasopharyngeal carcinoma. Acta Otolaryngol 2012;132:1197-207.
7. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG. Berberine inhibits HIF-1alpha expression via enhanced proteolysis. Mol Pharmacol 2004;66:612-19.
8. Panahi N, Mahmoudian M, Mortazavi P, Hashjin GS. Effects of berberine on b-secretase activity in a rabbit model of Alzheimer's disease. Arch Med Sci 2013;9:146-50.
9. Hamsa TP, Kuttan G. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. Drug Chem Toxicol 2012;35:57-70.
10. Hur JM, Hyun MS, Lim SY, Lee WY, Kim D. The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. J Cell Biochem 2009;107: 955-64.
11. Peng PL, Kuo WH, Tseng HC, Chou FP. Synergistic tumorkilling effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 2008;70:529-42.
12. Greer SN, Metcalf JL, Wang Y, Ohh M. The updated biology of hypoxia-inducible factor. EMBO J 2012;31:2448-60.
13. Wirthner R, Wrann S, Balamurugan K, Wenger RH, Stiehl DP. Impaired DNA double-strand break repair contributes to chemoresistance in HIF-1 alpha-deficient mouse embryonic fibroblasts. Carcinogenesis 2008;29: 2306-16.
14. Wan XB, Fan XJ, Liu Q. Aurora-A activation, correlated with hypoxia-inducible factor-1a, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma. Cancer Sci 2012;103:1586-94.
15. Shou Z, Lin L, Liang J, Li JL, Chen HY. Expression and prognosis of FOXO3a and HIF-1a in nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2012;138:585-93.
16. Xueguan L, Xiaoshen W, Yongsheng Z, Chaosu H, Chunying S, Yan F. Hypoxia inducible factor-1 alpha and vascular endothelial growth factor expression are associated with a poor prognosis in patients with nasopharyngeal carcinoma receiving radiotherapy with carbogen and nicotinamide. Clin Oncol 2008;20:606-12.
17. Xu Z, Fang S, Zuo Y, Zhang Y, Cheng R, Wang Q, et al. Combination of pigment epithelium-derived factor with radiotherapy enhances the antitumor effects on nasopharyngeal carcinoma by downregulating vascular endothelial growth factor expression and angiogenesis. Cancer Sci 2011;102:1789-98.
18. Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, Aggarwal BB. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factorkappaB-regulated antiapoptotic gene products, and potentiates apoptosis. Cancer Res 2008;68:5370-9.